AMPH · Amphastar Pharmaceuticals, Inc.

$22.01 +0.13 (+0.59%) At close · Aug 28

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$936.26M

42.54M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jack Yongfeng Zhang	Chief Executive Officer, President, Chief Scientific Officer and Director	$897,585	$393,739	$1,990,018	$1,989,985	$680,900	$17,515	$5,969,742
Mary Ziping Luo	Chief Operating Officer, Chief Scientist and Chairman	$731,679	$255,232	$840,017	$839,990	$288,600	$20,582	$2,976,100
Jason B. Shandell	Former President, General Counsel and Director	$869,996	$191,632	$790,027	$789,982	$237,300	$45,204	$2,924,141
William Peters	Chief Financial Officer, Senior Vice President of Finance, Treasurer, and President of International Medication Systems, Limited	$528,539	$113,939	$525,020	$524,989	$223,900	$40,633	$1,957,020
Rong Zhou	Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc.	$404,539	$151,251	$205,015	$204,991	$135,900	$32,772	$1,134,468

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jack Yongfeng Zhang	Chief Executive Officer, President, Chief Scientific Officer and Director	$1,091,539	$338,462	$1,939,994	$1,940,009	$549,869	$14,834	$5,874,707
Mary Ziping Luo	Chief Operating Officer, Chief Scientist and Chairman	$907,857	$207,116	$824,986	$825,021	$255,312	$13,241	$3,033,533
Jason B. Shandell	Former President, General Counsel and Director	$593,616	$171,347	$789,997	$790,009	$199,623	$39,795	$2,584,387

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jack Yongfeng Zhang	Chief Executive Officer, President, Chief Scientific Officer and Director	$880,000	$296,154	$2,089,996	$2,090,004	$372,300	$27,078	$5,755,532
Mary Ziping Luo	Chief Operating Officer, Chief Scientist and Chairman	$718,001	$203,664	$899,990	$900,014	$220,800	$13,538	$2,956,007
Jason B. Shandell	Former President, General Counsel and Director	$574,001	$162,818	$849,995	$850,007	$149,000	$29,106	$2,614,927

Executive changes

Person	Role	Change	Effective	Filed
Anthony Pierce	Class III director	Appointed	2026-07-09	2026-07-13
David Gaugh	Class I director	Appointed	2025-07-18	2025-07-21
Michael A. Zasloff	Class II director	Appointed	2024-06-03	2024-06-04
Gayle Deflin	Class II director	Appointed	2024-06-03	2024-06-04
Howard Lee	Class II director	Appointed	2024-06-03	2024-06-04
Mary Ziping Luo	Class II director	Appointed	2024-06-03	2024-06-04
Jacob Liawatidewi	Class I director	Appointed	2022-08-04	2022-08-09
William J. Peters	Class I director	Appointed	2022-08-04	2022-08-09
David Maris	Board of Directors	Resigned	2021-08-19	2021-08-23
Richard Koo	Board of Directors	Retired	2021-09-30	2021-08-10
Jason B. Shandell	member of the Board	Resigned	2020-04-13	2020-04-13

Key facts CIK 1297184 CUSIP 03209R103 13F (30d) 169 filings 167 filers Visit website Investor relations